Detecting cancer gene mutations from home: What you need to know

By Allison MacAlister CCSN Communications & Social Media Coordinator On March 6th 2018, the DNA test company 23andMe announced that it now has approval to tell customers of their mail-in DNA-testing kit about three gene mutations of BRCA1 and BRCA2 as part of their genetic health results. What does that mean, and is it worth